Bidness ETCFDA panel gives a thumb's up to Amgen's T-Vec for melanomaFierceBiotechAmgen's regulatory team for talimogene laherparepvec (T-Vec) was grilled by a group of outside FDA experts who picked up on some major questions regarding the Phase III melanoma study that was used to back its new drug application. A vigorous defense ...FDA Panel Gives Thumbs-Up To Amgen's Virus-Based Melanoma DrugForbesFDA panel recommends approval for Amgen's skin cancer immunotherapyReutersFDA Panels Support Approval of T-VEC in MelanomaOncLiveHealio -Zacks.comall 19 news articles »
FDA panel gives a thumb's up to Amgen's T
Rating: 4.5
Diposkan Oleh: Unknown
